Triple
T219131
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Department of Health and Social Care |
E4174
|
entity |
| Predicate | oversees |
P46
|
FINISHED |
| Object |
Human Tissue Authority
The Human Tissue Authority is a UK regulatory body responsible for licensing and overseeing the removal, storage, use, and disposal of human bodies, organs, and tissue for purposes such as research, transplantation, and education.
|
E28433
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Human Tissue Authority | Statement: [Department of Health and Social Care, oversees, Human Tissue Authority]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Human Tissue Authority Context triple: [Department of Health and Social Care, oversees, Human Tissue Authority]
-
A.
Human Fertilisation and Embryology Authority
The Human Fertilisation and Embryology Authority is the UK’s independent regulator overseeing fertility treatment and embryo research to ensure safety, ethical standards, and compliance with the law.
-
B.
NHS Blood and Transplant
NHS Blood and Transplant is a UK special health authority responsible for providing a safe and reliable supply of blood, organs, and associated services to the National Health Service.
-
C.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
D.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Human Tissue Authority Triple: [Department of Health and Social Care, oversees, Human Tissue Authority]
Generated description
The Human Tissue Authority is a UK regulatory body responsible for licensing and overseeing the removal, storage, use, and disposal of human bodies, organs, and tissue for purposes such as research, transplantation, and education.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Human Tissue Authority Target entity description: The Human Tissue Authority is a UK regulatory body responsible for licensing and overseeing the removal, storage, use, and disposal of human bodies, organs, and tissue for purposes such as research, transplantation, and education.
-
A.
Human Fertilisation and Embryology Authority
The Human Fertilisation and Embryology Authority is the UK’s independent regulator overseeing fertility treatment and embryo research to ensure safety, ethical standards, and compliance with the law.
-
B.
NHS Blood and Transplant
NHS Blood and Transplant is a UK special health authority responsible for providing a safe and reliable supply of blood, organs, and associated services to the National Health Service.
-
C.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
D.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a2573508588190b522c2476d91acfe |
completed | Feb. 28, 2026, 2:47 a.m. |
| NER | Named-entity recognition | batch_69a25c5199d8819096736c11077adec3 |
completed | Feb. 28, 2026, 3:09 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a34d953f308190b15fc5768b5b5e6f |
completed | Feb. 28, 2026, 8:18 p.m. |
| NEDg | Description generation | batch_69a35076ef6881908918c19412e12efe |
completed | Feb. 28, 2026, 8:30 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69a350d687148190b673593b8aa0072e |
completed | Feb. 28, 2026, 8:32 p.m. |
Created at: Feb. 28, 2026, 2:53 a.m.